How to Build a Scalable Framework for FDA 21 CFR Part 11 and GxP Compliance
As life sciences companies expand their digital ecosystems, the pressure to maintain FDA 21 CFR Part 11 and GxP Compliance continues to rise. The regulatory landscape is no longer limited to simple document control and audit trails. Today, organizations must manage massive data flows from cloud systems, electronic records, AI-driven workflows, automated labs, and global clinical operations. Without a scalable compliance framework, even small gaps can lead to audit failures, fines, product delays, or reputational damage. This article explains how enterprises can build a future-ready, scalable, and technology-driven compliance foundation designed for modern data complexity. Why Scalability Matters in FDA 21 CFR Part 11 and GxP Compliance Traditional compliance systems were built to manage structured records inside isolated applications. But today’s environment includes: Distributed cloud platforms AI/ML pipelines Cross-site manufacturing Global supply chains Hybr...